Highly Parallel Profiling of Enzymes In Vivo Using Mass-Encoded Substrate Libraries
Non-Exclusively Licensed
Invention type: Technology
/
Case number: #13062
The present invention relates to methods and products associated with in vivo enzyme profiling. In particular, the invention relates to methods of in vivo processing of exogenous molecules followed by detection of signature molecules as representative of the presence of active enzymes associated with diseases or conditions. The invention also relates to products, kits, and databases for use in the methods of the invention.
Researchers
Sangeeta Bhatia
/
Gabriel Kwong
/
Geoffrey Von Maltzahn
Departments: Health Sciences and Technology Program
Technology Areas: Biotechnology: Sensors & Monitoring / Diagnostics: Assays / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
methods and products for in vivo enzyme profiling
United States of America | Granted | 11,549,951 -
methods and products for in vivo enzyme profiling
United States of America | Granted | 8,673,267 -
methods and products for in vivo enzyme profiling
European Patent Convention | Granted | 2,403,964 -
methods and products for in vivo enzyme profiling
Japan | Granted | 6,067,225 -
methods and products for in vivo enzyme profiling
United States of America | Granted | 9,970,941 -
methods and products for in vivo enzyme profiling
United States of America | Granted | 10,883,998 -
methods and products for in vivo enzyme profiling
United States of America | Granted | 11,703,510 -
methods and products for in vivo enzyme profiling
European Patent Convention | Published application -
methods and products for in vivo enzyme profiling
Liechtenstein | Granted | 2,403,964 -
methods and products for in vivo enzyme profiling
United Kingdom | Granted | 2,403,964
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.